Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis T Cells Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me